Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm
MP Guillaume, H Reumaux, F Dubos - Cardiology in the Young, 2018 - cambridge.org
MP Guillaume, H Reumaux, F Dubos
Cardiology in the Young, 2018•cambridge.orgKawasaki disease is an acute self-limited vasculitis of unknown aetiology. The prognosis
depends mainly on coronary damage. There is no consensus regarding optimal adjunctive
therapeutics for refractory forms to treatment by intravenous immunoglobulins and
corticosteroids. We report the case of an 18-month-old infant with refractory Kawasaki
disease complicated by diffuse aneurysms of coronary arteries and successfully treated by
anakinra with partial regression of coronary aneurysms
depends mainly on coronary damage. There is no consensus regarding optimal adjunctive
therapeutics for refractory forms to treatment by intravenous immunoglobulins and
corticosteroids. We report the case of an 18-month-old infant with refractory Kawasaki
disease complicated by diffuse aneurysms of coronary arteries and successfully treated by
anakinra with partial regression of coronary aneurysms
Kawasaki disease is an acute self-limited vasculitis of unknown aetiology. The prognosis depends mainly on coronary damage. There is no consensus regarding optimal adjunctive therapeutics for refractory forms to treatment by intravenous immunoglobulins and corticosteroids. We report the case of an 18-month-old infant with refractory Kawasaki disease complicated by diffuse aneurysms of coronary arteries and successfully treated by anakinra with partial regression of coronary aneurysms
Cambridge University Press